Center for Scientific Review; Notice of Closed Meetings

• Citation: 91 FR 41646
• Published date: 07 July 2026
• FR Document: 2026-13686
• Pages: 41646-41648
• Section: Notices
• Issuer: Health and Human Services Department,National Institutes of Health

41646

Federal Register / Vol. 91, No. 128 / Tuesday, July 7, 2026 / Notices

Cost: The meeting is free and open to

the public.

Registration: A registration web link

will be posted on the IACC website

(iacc.hhs.gov) prior to the meeting. Pre-

registration is required for in-person

attendance.

Deadlines: Public Comment Due Date:

Friday, July 17, by 5:00 p.m. ET, Public

Comment Guidelines, For public

comment instructions, see below.

Contact Person: Ms. Rebecca Martin,

Office of National Autism Coordination,

National Institute of Mental Health,

NIH, Phone: 301–435–0886, Email:

IACCPublicInquiries@mail.nih.gov.

Public Comments

The IACC welcomes written and oral/

virtual public comments from members

of the autism community and asks the

community to review and adhere to its

Public Comment Guidelines. In the

2021–2023 IACC Strategic Plan, the

IACC lists the ‘‘Spirit of Collaboration’’

as one of its core values, stating that,

‘‘We will treat others with respect, listen

with open minds to the diverse lived

experiences of people on the autism

spectrum and their families, consider

multiple solutions, and foster

discussions where participants can

comfortably share different opinions.’’

In keeping with this core value, the

IACC and the NIMH Office of Autism

Research Coordination (OARC) ask that

members of the public who provide

public comments or participate in

meetings of the IACC also adhere to this

core value.

A limited number of slots are

available for individuals to provide a

∼3-minute summary or excerpt of their

written comment to the Committee

during the meeting either in person or

via videoconference. For those

interested in that opportunity, please

indicate ‘‘Interested in providing oral/

virtual comment’’ in your written

submission, along with your name,

address, email, phone number, and

professional/organizational affiliation so

that OARC staff can contact you if a slot

is available.

For any given meeting, priority for

comment slots will be assigned to

individuals and organizations that have

not previously provided comments in

the current calendar year. This will help

ensure that as many individuals and

organizations as possible have an

opportunity to share comments.

Commenters going over their allotted 3-

minute slot may be asked to conclude

immediately in order to allow other

comments and the rest of the meeting to

proceed on schedule.

Public comment submissions received

by 5:00 p.m. ET on Friday, July 17,

2026, will be provided to the Committee

prior to the meeting for their

consideration. Any written comments

received after 5:00 p.m. ET, Friday, July

17, 2026, may be provided to the

Committee either before or after the

meeting, depending on the volume of

comments received and the time

required to process them in accordance

with privacy regulations and other

applicable Federal policies. The

Committee is not able to respond

individually to comments. All public

comments become part of the public

record. Attachments of copyrighted

publications are not permitted, but web

links or citations for any copyrighted

works cited may be provided. For public

comment guidelines, see: https://

iacc.hhs.gov/meetings/public-

comments/guidelines/.

Technical issues: If you experience

any technical problems with the

webcast, please email

IACCPublicInquiries@mail.nih.gov.

Disability Accommodations: All IACC

Full Committee Meetings provide

Closed Captioning through the NIH

videocast website. Individuals whose

full participation in the meeting will

require special accommodations (e.g.,

sign language or interpreting services,

etc.) must submit a request to the

Contact Person listed on the notice at

least seven (7) business days prior to the

meeting. Such requests should include

a detailed description of the

accommodation needed and a way for

the IACC to contact the requester if

more information is needed to fill the

request. Special requests should be

made at least seven (7) business days

prior to the meeting; last-minute

requests may be made but may not be

possible to accommodate.

Security: Pre-registration is required

for in-person attendance. Upon arrival,

all attendees will be required to

complete the check-in process. Visitors

should be prepared to state the purpose

of their visit and present a valid form of

identification, such as a REAL ID-

compliant identification, U.S. passport,

or proof of legal U.S. residency. Non-

U.S. persons must pre-register at least

10 business days in advance and wait

for approval to attend. Seating will be

available on a first-come, first-served

basis.

Meeting schedule is subject to change.

More Information: Information about

the IACC is available on the website:

https://iacc.hhs.gov.

Dated: July 2, 2026.

Rosalind M. Niamke,

Program Analyst, Office of Federal Advisory

Committee Policy.

[FR Doc. 2026–13714 Filed 7–6–26; 8:45 am]

BILLING CODE 4167–05–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases;

Amended Notice of Meeting

Notice is hereby given of a change in

the meeting of the National Diabetes and

Digestive and Kidney Diseases Advisory

Council, September 17, 2026, 08:30 a.m.

to September 18, 2026, 04:00 p.m.,

National Institutes of Health, Building

31, 31 Center Drive, Bethesda, M, 20892

which was published in the Federal

Register on July 24, 2025, 90 FR 34872.

This notice is being amended to

reflect the change in date from

September 17–18, 2026, to October 28,

2026. The time will change from 8:30

a.m. to 4:00 p.m. to 8:30 a.m. to 3:00

p.m. The meeting format will adjust

from in-person/virtual to virtual only.

The meeting is partially closed to the

public.

Dated: July 1, 2026.

Margaret N. Vardanian,

Program Analyst, Office of Federal Advisory

Committee Policy.

[FR Doc. 2026–13635 Filed 7–6–26; 8:45 am]

BILLING CODE 4167–05–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 1009 of the

Federal Advisory Committee Act, as

amended, notice is hereby given of the

following meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel; Cognitive

VerDate Sep<11>2014 17:51 Jul 06, 2026 Jkt 268001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\07JYN1.SGM 07JYN1

khammond on DSK9W7S144PROD with NOTICES6

41647

Federal Register / Vol. 91, No. 128 / Tuesday, July 7, 2026 / Notices

and Language Habilitation and

Rehabilitation.

Date: July 29, 2026.

Time: 9:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Devon Rene Oskvig, Ph.D.,

Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Bethesda, MD

20892, (301) 594–9088, devon.oskvig@

nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel; Training

and Career Development: Healthcare, Health

Promotion & Implementation.

Date: July 30–31, 2026.

Time: 9:30 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Helen Huang, Ph.D.,

Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Bethesda, MD

20892, (301) 594 8934, helen.huang@nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel;

Fellowships: Physiology and Pathobiology of

Cardiovascular and Respiratory Systems.

Date: July 30, 2026.

Time: 10:00 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Yuanyi Feng, Ph.D.,

Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Dr., Bethesda, MD

20892, (301) 594–1180, fengy7@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel; PAR Panel:

International Research Scientist Development

Awards.

Date: July 30, 2026.

Time: 10:00 a.m. to 2:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Shiv A. Prasad, Ph.D.,

Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Rockville, MD

20892, (301) 594–4377, shiv.prasad@nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel; PAR Panel:

Clinical Care and Interventions for Substance

Use Disorder, Prevention, and Treatment of

Addiction.

Date: July 30–31, 2026.

Time: 10:00 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Cristina Lyn Reitz-Krueger,

Ph.D., Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Bethesda, MD

20892, (301) 480–2060, cristina.reitz-

krueger@nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel; Member

Conflict: SEP for R01 and R21 applications.

Date: July 30, 2026.

Time: 10:00 a.m. to 8:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Lee Warren Slice, MS, BA,

Ph.D., Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Bethesda, MD

20892, (301) 402 9286, slicelw@mail.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel; Contracts:

Development of Radiological/Nuclear

Medical Countermeasures (MCMs) And

Biodosimetry Devices.

Date: July 30–31, 2026.

Time: 10:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate contract

proposals.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Hailey P. Weerts, Ph.D.,

Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Bethesda, MD

20892, (301) 594 3506, hailey.weerts@

nih.gov.

Name of Committee: Population Sciences

and Epidemiology Integrated Review Group;

Aging, Injury, Musculoskeletal, and

Rheumatologic Disorders Study Section.

Date: July 30–31, 2026.

Time: 10:00 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Nketi I. Forbang, MD,

MPH, Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 1006K1,

Bethesda, MD 20892, (301) 594–0357,

forbangni@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel; Early

Development of Vaccines Against Infectious

Diseases.

Date: July 30, 2026.

Time: 10:00 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Vanitha Sundaresa Raman,

Ph.D., Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Bethesda, MD

20892, 301–594–3950, vanitha.raman@

nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel;

Fellowships: Pregnancy, Reproduction and

Metabolism.

Date: July 30, 2026.

Time: 10:30 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Santanu Banerjee, Ph.D.,

Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 2106,

Bethesda, MD 20892, (301) 435–5947,

banerjees5@mail.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel; Motivated

Behavior, Alcohol, and Addictive

Substances.

Date: July 30, 2026.

Time: 11:00 a.m. to 7:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Mamatha Garige, Ph.D.,

Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Bethesda, MD

20892, (301) 443–1706, mamatha.garige@

nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel;

Fellowships: Alzheimer’s and

Neurodegeneration II.

Date: July 30, 2026.

Time: 11:00 a.m. to 4:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Patricia Manos Kraemer,

Ph.D., Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5200,

MSC 7846, Bethesda, MD 20892, (301) 827–

2551, manospa@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel; PAR–24–

129: Specific Pathogen Free Macaque

Colonies.

Date: July 30, 2026.

Time: 2:00 p.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Tori Stone, Ph.D.,

Scientific Review Officer, Center for

Scientific Review, National Institutes of

VerDate Sep<11>2014 17:51 Jul 06, 2026 Jkt 268001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\07JYN1.SGM 07JYN1

khammond on DSK9W7S144PROD with NOTICES6

41648

Federal Register / Vol. 91, No. 128 / Tuesday, July 7, 2026 / Notices

Health, 6701 Rockledge Drive, Bethesda, MD

20892, (301) 594–7549, tori.stone@nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel; Member

Conflict: Topics in Basic Neuroscience.

Date: July 30, 2026.

Time: 12:00 p.m. to 3:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Marta Veronica Hamity,

Ph.D., Scientific Review Officer, Center for

Scientific Review, National Institute of

Health, 6701 Rockledge Drive, Bethesda, MD

20892, (301) 451–1664, marta.hamity@

nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel; Topics in

drug development, toxicology, and delivery.

Date: July 30, 2026.

Time: 12:00 p.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Address: National Institutes of Health,

Rockledge II, 6701 Rockledge Drive,

Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Heidi B. Friedman, Ph.D.,

Scientific Review Officer, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 907–H,

Bethesda, MD 20892, (301) 827 3055,

hfriedman@csr.nih.gov.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine;

93.333, Clinical Research, 93.306, 93.333,

93.337, 93.393–93.396, 93.837–93.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, HHS)

Dated: July 1, 2026.

Bruce A. George,

Program Analyst, Office of Federal Advisory

Committee Policy.

[FR Doc. 2026–13686 Filed 7–6–26; 8:45 am]

BILLING CODE 4167–05–P

DEPARTMENT OF HOMELAND

SECURITY

U.S. Citizenship and Immigration

Services

[OMB Control Number 1615–0114]

Agency Information Collection

Activities; Extension, Without Change,

of a Currently Approved Collection:

Application for Civil Surgeon

Designation

AGENCY

: U.S. Citizenship and

Immigration Services, Department of

Homeland Security.

ACTION

: 30-Day notice.

SUMMARY

: The Department of Homeland

Security (DHS), U.S. Citizenship and

Immigration Services (USCIS) will be

submitting the following information

collection request to the Office of

Management and Budget (OMB) for

review and clearance in accordance

with the Paperwork Reduction Act of

1995. The purpose of this notice is to

allow an additional 30 days for public

comments.

DATES

: Comments are encouraged and

will be accepted until August 6, 2026.

ADDRESSES

: Written comments and/or

suggestions regarding the item(s)

contained in this notice, especially

regarding the estimated public burden

and associated response time, must be

submitted via the Federal eRulemaking

Portal website at http://

www.regulations.gov under e-Docket ID

number USCIS–2013–0002. All

submissions received must include the

OMB Control Number 1615–0114 in the

body of the letter, the agency name and

Docket ID USCIS–2013–0002.

FOR FURTHER INFORMATION CONTACT

:

USCIS, Office of Policy and Strategy,

Regulatory Coordination Division, John

R. Pfirrmann-Powell, Acting Deputy

Chief, telephone number (240) 721–

3000 (This is not a toll-free number;

comments are not accepted via

telephone message.). Please note contact

information provided here is solely for

questions regarding this notice. It is not

for individual case status inquiries.

Applicants seeking information about

the status of their individual cases can

check Case Status Online, available at

the USCIS website at http://

www.uscis.gov, or call the USCIS

Contact Center at 800–375–5283 (TTY

800–767–1833).

SUPPLEMENTARY INFORMATION

:

Comments

The information collection notice was

previously published in the Federal

Register on April 20, 2026, at 91 FR

21012, allowing for a 60-day public

comment period. USCIS did receive one

comment in connection with the 60-day

notice.

You may access the information

collection instrument with instructions,

or additional information by visiting the

Federal eRulemaking Portal site at:

http://www.regulations.gov and enter

USCIS–2013–0002 in the search box.

Comments must be submitted in

English, or an English translation must

be provided. The comments submitted

to USCIS via this method are visible to

the Office of Management and Budget

and comply with the requirements of 5

CFR 1320.12(c). All submissions will be

posted, without change, to the Federal

eRulemaking Portal at http://

www.regulations.gov, and will include

any personal information you provide.

Therefore, submitting this information

makes it public. You may wish to

consider limiting the amount of

personal information that you provide

in any voluntary submission you make

to DHS. DHS may withhold information

provided in comments from public

viewing that it determines may impact

the privacy of an individual or is

offensive. For additional information,

please read the Privacy Act notice that

is available via the link in the footer of

http://www.regulations.gov.

Written comments and suggestions

from the public and affected agencies

should address one or more of the

following four points:

(1) Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information will have

practical utility;

(2) Evaluate the accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used;

(3) Enhance the quality, utility, and

clarity of the information to be

collected; and

(4) Minimize the burden of the

collection of information on those who

are to respond, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submission of

responses.

Overview of This Information

Collection

(1) Type of Information Collection

Request: Extension, Without Change, of

a Currently Approved Collection.

(2) Title of the Form/Collection:

Application for Civil Surgeon

Designation.

(3) Agency form number, if any, and

the applicable component of the DHS

sponsoring the collection: I–910; USCIS.

(4) Affected public who will be asked

or required to respond, as well as a brief

abstract: Primary: Business or other for-

profit. This information collection is

required to determine whether a

physician meets the statutory and

regulatory requirement for civil surgeon

designation. For example, all documents

are reviewed to determine whether the

physician has a currently valid medical

license and whether the physician has

had any action taken against him or her

by the medical licensing authority of the

U.S. state(s) or U.S. territories in which

he or she practices. If the Application

for Civil Surgeon Designation (Form I–

910) is approved, the physician is

included in USCIS’s public Civil

VerDate Sep<11>2014 17:51 Jul 06, 2026 Jkt 268001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\07JYN1.SGM 07JYN1

khammond on DSK9W7S144PROD with NOTICES6